Menarini nears €4.9 billion in 2025 and focuses on talent and AI as ‘giant’ players enter pharma Notified -
Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications Notified -
NOAA Determines TMC USA’s Consolidated Deep-Seabed Mining Application is in Substantial Compliance Notified -
Founder Group Limited Secures US$4 million 25.4MW Utility-Scale Solar Contract under Malaysia’s CGPP Programme Notified -
Acronis Releases 2025 ESG Report Highlighting Progress in Sustainability, Workforce Engagement, and Responsible Technology Notified -
